Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CLDI will decline by -12.14% over the next 2 Weeks and hit $1.07 by Monday, September 28, 2026. In that time frame, CLDI's share price is expected to range between $0.94 and $1.21.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 28, 2026 | 0.94 | 1.07 | 1.21 |
| Sep 25, 2026 | 0.98 | 1.10 | 1.24 |
| Sep 24, 2026 | 0.97 | 1.10 | 1.23 |
| Sep 23, 2026 | 1.00 | 1.13 | 1.26 |
| Sep 22, 2026 | 1.02 | 1.16 | 1.29 |
| Sep 21, 2026 | 1.02 | 1.14 | 1.27 |
| Sep 18, 2026 | 1.05 | 1.17 | 1.30 |
| Sep 17, 2026 | 1.04 | 1.17 | 1.31 |
| Sep 16, 2026 | 1.08 | 1.20 | 1.33 |
| Sep 15, 2026 | 1.10 | 1.23 | 1.37 |
CLDI shares fell -1.61% in Monday, September 14, 2026's trading session, dropping from a previous close of $1.24 to move at $1.22. The stock demonstrated notable intraday movement (see CLDI's key stats for a full breakdown), fluctuating between $1.21 and $1.27, a +4.96% trading range. While recent weeks have seen some volatility, CLDI has managed to secure a -8.96% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 17.49K shares changing hands, 53.13K fewer than the previous session. This amounted to $21.34K in total market activity.
Will CLDI Continue Its Downward Trend?
According to analyst ratings and projections for CLDI, Calidi Biotherapeutics, Inc. shares are anticipated to decrease by -1.10%, potentially reaching $1.21 per share by September 28, 2026. Short-term technical indicators currently suggest a neutral sentiment for CLDI. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the CLDI stock forecast, now is not the best time to buy CLDI stock because its current trading price is +13.82% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CLDI covering social and institutional perspectives.
CLDI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CLDI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 29.94% to 35.07%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 36.14%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.45%, maintains a neutral outlook for the long term. Insights into CLDI's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Calidi Biotherapeutics Short-Term Forecasts
CLDI Forecast For Next 5 Days
Our algorithm anticipates Calidi Biotherapeutics (CLDI) stock could hit $1.08 by Sep 21, 2026. This represents a -11.62% fall from today's price, following a -9.81% change over the past five days.
CLDI Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Calidi Biotherapeutics, Inc. (CLDI) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.03, which would mean a -15.57% decrease from the current price of $1.22. Projections for this period range from a high of $1.34 to a low of $0.78.
CLDI Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Calidi Biotherapeutics's price over the next three months point to a drop. CLDI stock is expected to peak at $176.61 on Nov 26, 2026 before potentially dipping to $0.00 on Dec 15, 2026. On average, CLDI is likely to trade around $0.00 in the coming 90 days.
Calidi Biotherapeutics Stock Forecast 2025
Based on our predictive models, Calidi Biotherapeutics (CLDI) is expected to trade between $0.00 and $176.61 throughout 2026. This would result in an average price of $0.00, potentially offering investors a -100.00% return from current levels.
Calidi Biotherapeutics, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $156.81, settling at an average of $0.01. This could translate to a -99.18% loss.
October 2026
Based on current market signals, Calidi Biotherapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $165.72, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
November 2026
Our predictive algorithms indicate Calidi Biotherapeutics, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$176.61, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
December 2026
Analyzing established trends, Calidi Biotherapeutics, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $158.55, averaging around $0.00. This suggests a -100.00% loss from current levels.
January 2027
Market indicators suggest Calidi Biotherapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $151.17, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
February 2027
Forecasting for February 2027, models estimate that Calidi Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $171.43, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
March 2027
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $168.66, settling at an average of $0.00. This could translate to a -100.00% loss.
April 2027
Based on current market signals, Calidi Biotherapeutics, Inc. is projected to trend april 2027. We forecast a trading range from $0.00 to $149.66, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
May 2027
Our predictive algorithms indicate Calidi Biotherapeutics, Inc. stock may see a shift in May 2027. The expected range spans $0.00–$159.18, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
June 2027
Analyzing established trends, Calidi Biotherapeutics, Inc. looks set to move in June 2027. Projections place the stock between $0.00 and $154.80, averaging around $0.00. This suggests a -100.00% loss from current levels.
July 2027
Market indicators suggest Calidi Biotherapeutics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $0.00 to $161.20, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
August 2027
Forecasting for August 2027, models estimate that Calidi Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $162.65, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
September 2027
According to our latest forecast models, Calidi Biotherapeutics, Inc. (CLDI) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.00 and $162.92, settling at an average of $0.00. This could translate to a -100.00% loss.
CLDI's history of dividends and stock splits also plays a role in long-term investor confidence.